Company: PTHS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001753926-25-001764
Chunk: 56

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 56
---
 
     (1,112) 
    $226.80  

    Exercised 
     —  
    $—  

    Outstanding September 30, 2024 
     82,044  
    $61.60  
     9.40 years 

    Exercisable September 30, 2024 
     20,890  
    $145.70  
     8.87 years 

The
following weighted-average assumptions were used to estimate the fair value of stock options granted during the nine months ended
September 30, 2025 and 2024:

    Nine Months Ended September 30, 

    2025  
    2024 

    Expected volatility 
     86.11% 
     196.00%

    Risk-free interest rate 
     4.28% 
     4.20%

    Expected term (in years) 
     5.94  
     10.00 

    Expected dividend yield 
     —% 
     —%

    Weighted-average fair value per option 
    $10.02  
    $12.98 

    35

Restricted
Stock Units

The
activity related to RSUs during the nine months ended September 30, 2025 consisted of the following:

    Non-vested RSUs 
    RSUs  
    Weighted-  Average  Exercise  Price  

    Non-vested at December 31, 2024 
     29,219  
    $10.80 

    Granted 
     476,157  
     13.54 

    Vested 
     (31,425) 
     12.23 

    Forfeited 
     (2,464) 
     13.50 

    Non-vested at September 30, 2025 
     471,487  
    $13.45 

The
activity related to RSUs during the nine months ended September 30, 2024 consisted of the following:

    Non-vested RSUs 
    RSUs  
    Weighted-  Average  Exercise  Price  

    Non-vested at December 31, 2023 
     —  
    $— 

    Granted 
     25,800  
    $13.00 

    Vested